Get startedLog in
    Picture of SCHOTT Pharma AG & Co. KGaA logo

    1SXP — SCHOTT Pharma AG & Co. KGaA News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Schott Pharma Q3 Revenues Up 1% YoY To EUR 256 Mln

    Picture of SCHOTT Pharma AG & Co. KGaA logoSCHOTT Pharma AG & Co. KGaA
    12/08/2025 06:02
    Aug 12 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE:

SCHOTT PHARMA AG & CO KGAA - Q3 2025 REVENUES UP 1% YOY TO EUR 256M; INCREASE OF 3% YOY AT CONSTANT CURRENCIES

SCHOTT PHARMA AG & CO KGAA - Q3 2025 EBITDA MARGIN OF 32.4% AS REPORTED AND 31.7% AT CONSTANT CURRENCIES

SCHOTT PHARMA AG & CO KGAA - EBITDA MARGIN FOR FY 2025 IS EXPECTED TO BE AROUND 28.0%

SCHOTT PHARMA AG & CO KGAA - ORGANIC REVENUE GROWTH FOR FY 2025 IS EXPECTED TO BE AROUND 6.0%

Source text: ID:nEQ7GBMhya

Further company coverage: 1SXP.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SCHOTT Pharma AG & Co. KGaA

    See all news